Germany: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Germany

After five years of growth, the German medicaments containing hormones market decreased by X% to $X in 2023. In general, the total consumption indicated a resilient increase from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption increased by X% against 2017 indices. Medicaments containing hormones consumption peaked at $X in 2022, and then fell in the following year.

Medicaments Containing Hormones Production in Germany

In value terms, medicaments containing hormones production declined to $X in 2023 estimated in export price. Overall, the total production indicated buoyant growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production increased by X% against 2018 indices. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, production reached the maximum level at $X in 2022, and then declined in the following year.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Medicaments Containing Hormones Exports

Exports from Germany

In 2023, overseas shipments of medicaments containing hormones but not antibiotics were finally on the rise to reach X tons for the first time since 2019, thus ending a three-year declining trend. Overall, exports, however, saw a perceptible decline. The exports peaked at X tons in 2012; however, from 2013 to 2023, the exports remained at a lower figure.

In value terms, medicaments containing hormones exports surged to $X in 2023. In general, exports, however, continue to indicate a abrupt setback. Over the period under review, the exports hit record highs at $X in 2012; however, from 2013 to 2023, the exports failed to regain momentum.

Exports by Country

Japan (X tons) was the main destination for medicaments containing hormones exports from Germany, accounting for a X% share of total exports. Moreover, medicaments containing hormones exports to Japan exceeded the volume sent to the second major destination, Australia (X tons), ninefold.

From 2012 to 2023, the average annual growth rate of volume to Japan totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Australia (X% per year) and the United States (X% per year).

In value terms, Japan ($X) remains the key foreign market for medicaments containing hormones but not antibiotics exports from Germany, comprising X% of total exports. The second position in the ranking was held by Australia ($X), with a X% share of total exports.

From 2012 to 2023, the average annual growth rate of value to Japan stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Australia (X% per year) and the United States (X% per year).

Export Prices by Country

The average medicaments containing hormones export price stood at $X per ton in 2023, rising by X% against the previous year. In general, the export price, however, saw a pronounced slump. The pace of growth was the most pronounced in 2017 when the average export price increased by X%. As a result, the export price attained the peak level of $X per ton. From 2018 to 2023, the average export prices remained at a lower figure.

There were significant differences in the average prices for the major export markets. In 2023, amid the top suppliers, the country with the highest price was Australia ($X per ton), while the average price for exports to Japan ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to the United States (X%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Hormones Imports

Imports into Germany

In 2023, the amount of medicaments containing hormones but not antibiotics imported into Germany contracted dramatically to X tons, with a decrease of X% compared with the previous year. In general, imports, however, posted a strong increase. The pace of growth appeared the most rapid in 2022 with an increase of X%. Imports peaked at X tons in 2020; however, from 2021 to 2023, imports stood at a somewhat lower figure.

In value terms, medicaments containing hormones imports rose remarkably to $X in 2023. Overall, imports, however, continue to indicate a prominent increase. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, imports hit record highs at $X in 2020; however, from 2021 to 2023, imports remained at a lower figure.

Imports by Country

In 2023, the United States (X tons) was the main medicaments containing hormones supplier to Germany, with a X% share of total imports. Moreover, medicaments containing hormones imports from the United States exceeded the figures recorded by the second-largest supplier, the Netherlands (X kg), more than tenfold. The third position in this ranking was held by Taiwan (Chinese) (X kg), with a X% share.

From 2012 to 2023, the average annual rate of growth in terms of volume from the United States amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: the Netherlands (X% per year) and Taiwan (Chinese) (X.3% per year).

In value terms, the United States ($X) constituted the largest supplier of medicaments containing hormones but not antibiotics to Germany, comprising X% of total imports. The second position in the ranking was taken by the Netherlands ($X), with a X% share of total imports. It was followed by Belgium, with a X% share.

From 2012 to 2023, the average annual rate of growth in terms of value from the United States totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: the Netherlands (X% per year) and Belgium (X% per year).

Import Prices by Country

In 2023, the average medicaments containing hormones import price amounted to $X per kg, growing by X% against the previous year. In general, the import price continues to indicate pronounced growth. Over the period under review, average import prices attained the peak figure at $X per kg in 2013; however, from 2014 to 2023, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the United States ($X per kg), while the price for Austria ($X per kg) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Belgium (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform